Analysis of Nimodipine API final produt

Significance of the Topic

Nimodipine is a widely used calcium channel blocker with critical applications in neurology and cardiology. Ensuring the purity of its active pharmaceutical ingredient (API) is vital for patient safety and regulatory compliance. Robust analytical methods are required to detect and quantify trace impurities in the final API product.

Objectives and Overview of the Study

The primary goal was to develop and demonstrate a rapid, accurate, and reproducible reversed-phase liquid chromatography (RP-LC) method for the quantitative analysis of nimodipine and its related impurities in the final API formulation. The study outlines method development, system suitability evaluation, and proof of concept using standard mixtures and API samples.

Methodology and Instrumentation

Instrumentation details are summarized in the section “Used Instrumentation.”

Used Instrumentation

• Column: Shim-pack Velox PFPP, 250 mm × 4.6 mm I.D., 5 μm
• Mobile Phase: A = 0.02 M KH₂PO₄ buffer with KOH, pH 6.0; B = acetonitrile (A:B = 60:40)
• Flow Rate: 1.0 mL/min (isocratic)
• Column Temperature: 40 °C
• Injection Volume: 20 μL
• Vials: LabTotal™ Vials for LC/LCMS
• Detection: UV at 235 nm

Main Results and Discussion

• Baseline separation of nimodipine and ten related impurities was achieved under isocratic conditions.
• Chromatograms of standard mixtures demonstrated clear, well-resolved peaks for impurities J, 6, I, 3, 2, H, L, 5, K, and nimodipine.
• System suitability tests confirmed reproducible retention times and peak shapes, supporting method reliability.
• The method showed adequate sensitivity for impurity detection at low microgram-per-milliliter levels.

Benefits and Practical Applications

• The isocratic RP-LC method offers simplicity and robustness for routine quality control of nimodipine API.
• Fast analysis time and reproducible results support high laboratory throughput.
• Compatibility with standard UV detection reduces operational costs.
• A straightforward buffer–organic mobile phase composition ensures easy preparation and consistency.

Future Trends and Opportunities

The following developments could enhance this analytical approach:

• Integration with mass spectrometry to improve sensitivity and structural confirmation of unknown impurities.
• Adoption of ultra-high-performance LC (UHPLC) for faster run times and reduced solvent consumption.
• Implementation of green chemistry principles by exploring alternative, eco-friendly solvents.
• Automation and data analytics for real-time monitoring and predictive maintenance of chromatographic systems.

Conclusion

A robust, reproducible isocratic RP-LC method using a phenyl-based PFPP column has been established for the quantitative analysis of nimodipine API and its related impurities. The approach meets system suitability criteria and provides reliable, cost-effective quality control for pharmaceutical manufacturing.